Balgrist University Hospital
balgrist.chTotal trials
80
Active
11
Phase 3
6
Total enrollment
11,444
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| NaCl 0.9% | — | — | — | — | — | 2 | |
| Standard antibiotic prophylaxis | — | — | — | — | — | 1 | |
| Dexamethasone 4 Mg/mL Injectable Solution | — | — | — | — | — | 1 | |
| duration of standard antibiotic therapy | — | — | — | — | — | 1 |
Next readouts
- 2024-07-31
- 2024-12-12
- 2025-02-28
Top conditions
- Neck Pain4
- Sarcoma3
- Rotator Cuff Tear3
- Low Back Pain3
- Healthy3
- Soft Tissue Sarcoma2
- Sarcoma of Bone2
- Osteoarthritis, Knee2
Frequently asked questions about Balgrist University Hospital
- How many clinical trials does Balgrist University Hospital have on ClinicalTrials.gov?
- Balgrist University Hospital is listed as the lead sponsor on 80 clinical trials in ClinicalTrials.gov, 11 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Balgrist University Hospital's trials are in Phase 3?
- 6 of Balgrist University Hospital's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Balgrist University Hospital focus on?
- Balgrist University Hospital's most-studied conditions on ClinicalTrials.gov are Neck Pain, Sarcoma, Rotator Cuff Tear, Low Back Pain, Healthy.
- When are Balgrist University Hospital's next clinical trial readouts?
- Balgrist University Hospital has 3 upcoming primary-completion readouts tracked here; the soonest is “Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy”, expected around 2024-07-31.